Fusing technology and intelligence to improve patient care
Earlier this year Cardinal Health announced plans to spin-off its clinical and medical products businesses as a separate, publicly traded company.
Since 1 July, this new company is known as CareFusion Corporation. CareFusion became a separate publicly traded company on 1 Sept 2009 from the spinoff of Cardinal Health's clinical and medical products businesses. With more than 15,000 employees in more than 120 countries worldwide they help caregivers measurably improve patient care by focusing on two of the biggest issues affecting healthcare - medication errors and hospital-acquired infections.
The family of products and services are used in over 120 countries and include some of the most widely recognised brand names in their categories:
- Pyxis® for medication and supply management
- Alaris® for infusion
- AVEA® and Pulmonetic Systems™ for ventilation
- Jaeger®, SensorMedics® and Micro Medical for respiratory diagnostic instruments
- AVAmax® and PleurX® for interventional procedures
- V. Mueller® and Snowden-Pencer® for surgical instruments
- Nicolet neurodiagnostic instruments
- MedMined™ for infection surveillance
- ChloraPrep® for infection prevention
The CareFusion difference
The approach is bold – we're unafraid to try new things, adopt unconventional strategies and create new resources in our ongoing quest to help create safer outcomes at the point of care.
We understand the human side of our business – recognising that healthcare systems must be built around people. We measure our success by the impact we have on caregivers, who devote their lives to helping others, and on the patients who trust us during their greatest hours of need.
CareFusion has two solution portfolios and reporting segments: Critical Care Technologies and Medical Technologies and Services. Each is comprised of market-leading products and services. Please see the Product List for details on these.
3750 Torrey View Court
San Diego, CA 92130